McGovern Medical School at the University of Texas Health is a clinical research site located in Houston, Texas, United States 77004.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
McGovern Medical School at the University of Texas Health has participated in 1 clinical trials.
Therapeutic areas: Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).
Sponsors: Novartis Pharmaceuticals.
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
McGovern Medical School at the University of Texas Health has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
McGovern Medical School at the University of Texas Health has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).
McGovern Medical School at the University of Texas Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.